Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acthar Gel in Pulmonary Sarcoidosis
NCT03320070Phase 4Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Feb 2018
- Primary completion
- Nov 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of repository corticotropin injection in pulmonary sarcoidosis, sponsored by Mallinckrodt Pharmaceuticals. Started Feb 2018; status: completed.
02
Drugs
repository corticotropin injection
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on NCT03320070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03320070.